Modi Naturals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 20, 2025, 9:47 pm

Competitors of Modi Naturals Ltd

All Competitor Stocks of Modi Naturals Ltd

Quarterly Result

Last Updated: August 19, 2025, 12:55 pm

Below is a detailed analysis of the quarterly data for Modi Naturals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 155.00 Cr.. The value appears to be declining and may need further review. It has decreased from 190.00 Cr. (Mar 2025) to 155.00 Cr., marking a decrease of 35.00 Cr..
• For Expenses, as of Jun 2025, the value is 137.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 174.00 Cr. (Mar 2025) to 137.00 Cr., marking a decrease of 37.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 2.00 Cr..
• For OPM %, as of Jun 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Mar 2025) to 11.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 2.00 Cr..
• For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 22.00%, marking a decrease of 5.00%.
• For Net Profit, as of Jun 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 2.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 8.01. The value appears strong and on an upward trend. It has increased from 6.23 (Mar 2025) to 8.01, marking an increase of 1.78.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 12:51 pm

Growth

Last Updated: September 5, 2025, 3:51 pm

Balance Sheet

Last Updated: July 25, 2025, 1:00 pm

Below is a detailed analysis of the balance sheet data for Modi Naturals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
• For Reserves, as of Mar 2025, the value is 108.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2024) to 108.00 Cr., marking an increase of 31.00 Cr..
• For Borrowings, as of Mar 2025, the value is 149.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 170.00 Cr. (Mar 2024) to 149.00 Cr., marking a decrease of 21.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 59.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 46.00 Cr. (Mar 2024) to 59.00 Cr., marking an increase of 13.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 330.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 306.00 Cr. (Mar 2024) to 330.00 Cr., marking an increase of 24.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 145.00 Cr.. The value appears to be declining and may need further review. It has decreased from 149.00 Cr. (Mar 2024) to 145.00 Cr., marking a decrease of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 16.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 169.00 Cr.. The value appears strong and on an upward trend. It has increased from 157.00 Cr. (Mar 2024) to 169.00 Cr., marking an increase of 12.00 Cr..
• For Total Assets, as of Mar 2025, the value is 330.00 Cr.. The value appears strong and on an upward trend. It has increased from 306.00 Cr. (Mar 2024) to 330.00 Cr., marking an increase of 24.00 Cr..

However, the Borrowings (149.00 Cr.) are higher than the Reserves (108.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Modi Naturals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
• For Diluted EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
• For Cash EPS (Rs.), as of Mar 25, the value is 29.19. This value is within the healthy range. It has increased from 2.13 (Mar 24) to 29.19, marking an increase of 27.06.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 498.19. It has increased from 300.47 (Mar 24) to 498.19, marking an increase of 197.72.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 43.00. This value is within the healthy range. It has increased from 7.68 (Mar 24) to 43.00, marking an increase of 35.32.
• For PBIT / Share (Rs.), as of Mar 25, the value is 37.12. This value is within the healthy range. It has increased from 4.51 (Mar 24) to 37.12, marking an increase of 32.61.
• For PBT / Share (Rs.), as of Mar 25, the value is 28.33. This value is within the healthy range. It has increased from -1.30 (Mar 24) to 28.33, marking an increase of 29.63.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
• For PBDIT Margin (%), as of Mar 25, the value is 8.63. This value is below the healthy minimum of 10. It has increased from 2.55 (Mar 24) to 8.63, marking an increase of 6.08.
• For PBIT Margin (%), as of Mar 25, the value is 7.45. This value is below the healthy minimum of 10. It has increased from 1.50 (Mar 24) to 7.45, marking an increase of 5.95.
• For PBT Margin (%), as of Mar 25, the value is 5.68. This value is below the healthy minimum of 10. It has increased from -0.43 (Mar 24) to 5.68, marking an increase of 6.11.
• For Net Profit Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 5. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 8. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
• For Return on Networth / Equity (%), as of Mar 25, the value is 25.52. This value is within the healthy range. It has increased from -1.52 (Mar 24) to 25.52, marking an increase of 27.04.
• For Return on Capital Employeed (%), as of Mar 25, the value is 24.71. This value is within the healthy range. It has increased from 3.32 (Mar 24) to 24.71, marking an increase of 21.39.
• For Return On Assets (%), as of Mar 25, the value is 9.40. This value is within the healthy range. It has increased from -0.45 (Mar 24) to 9.40, marking an increase of 9.85.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has decreased from 0.94 (Mar 24) to 0.58, marking a decrease of 0.36.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.22. This value exceeds the healthy maximum of 1. It has decreased from 1.87 (Mar 24) to 1.22, marking a decrease of 0.65.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.08. It has increased from 1.41 (Mar 24) to 2.08, marking an increase of 0.67.
• For Current Ratio (X), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 1.5. It has decreased from 1.24 (Mar 24) to 1.22, marking a decrease of 0.02.
• For Quick Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 24) to 0.57, marking an increase of 0.10.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.61. This value is within the healthy range. It has increased from 3.28 (Mar 24) to 5.61, marking an increase of 2.33.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.89. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 4.89, marking an increase of 3.57.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.65. This value is within the healthy range. It has increased from 0.82 (Mar 24) to 3.65, marking an increase of 2.83.
• For Enterprise Value (Cr.), as of Mar 25, the value is 601.08. It has increased from 422.48 (Mar 24) to 601.08, marking an increase of 178.60.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 1.06 (Mar 24) to 0.90, marking a decrease of 0.16.
• For EV / EBITDA (X), as of Mar 25, the value is 10.51. This value is within the healthy range. It has decreased from 41.33 (Mar 24) to 10.51, marking a decrease of 30.82.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
• For Price / BV (X), as of Mar 25, the value is 3.75. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 24) to 3.75, marking an increase of 0.94.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.06, marking an increase of 0.07.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness